The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology,” Tuesday, June 19, 2012, from 11 am to 12 pm EDT
Register today for “The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology,” an educational, complimentary webinar hosted by Dr. Scott E. Boley and Ms. Lisa Craig.
Explore the advantages of Göttingen minipigs as an alternative nonrodent model in the development of therapeutics. With this model, multiple delivery routes beyond dermal can be used. Learn about
- Why many Sponsors choose Göttingen minipigs
- Why this model is accepted by regulatory authorities
Discover how this well-established model can be used in all aspects of nonclinical research.